Loading candles…
Blue Jet Healthcare, incorporated in 1968 and formerly known as Jet Chemicals Pvt Ltd, operates in the pharmaceutical, healthcare ingredients, and specialty chemicals industries. The company specializes in manufacturing saccharin and its salts, serving as India's first producer of these artificial sweeteners. Blue Jet Healthcare functions as a Contract Development and Manufacturing Organisation (CDMO), providing integrated services focused on niche chemistry areas including contrast media intermediates, high-intensity sweeteners, pharmaceutical intermediates, and Active Pharmaceutical Ingredients (APIs). Its business segments encompass contrast media intermediates, high-intensity sweeteners, pharmaceutical intermediates, and APIs. The company offers products and services such as saccharin and its salts, contract development and manufacturing services, and various intermediates related to pharmaceuticals and sweeteners.
This page is a live market overview for BLUE JET HEALTHCARE LTD (BLUEJET) on the NSE. As a listed security, BLUE JET HEALTHCARE LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for BLUEJET before placing trades on tick2trade.
As of the latest feed, BLUEJET last traded at ₹593.9 on NSE, up ₹6 (1.02%) from the previous close of ₹587.9. Today's session range is ₹583.1 – ₹599.45, against a 52-week band of ₹325 – ₹814. Traded volume today stands at 5.18L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for BLUEJET in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether BLUEJET is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for BLUE JET HEALTHCARE LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in BLUEJET. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated BLUEJET option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 3 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026, dividend and Fund Raising | 25 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 13 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 4 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 22 Jul 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025, dividend and Fund Raising | 14 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.